Company Overview: Corindus

Industry News

5 May

Corindus Vascular Robotics Reports First Quarter 2016 Results

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, today reported financial results for the three months ended March 31, 2016. Recent Highlights and Accomplishments Installed two new CorPath® Systems in the first quarter of 2016 increasing the total installed base to 40...

Read more

29 Mar

FDA Clears CorPath Robotic System for Use in Peripheral Vascular Intervention

Expanded indication highlights continued development progress for vascular robotics WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics, Inc. , a leading developer of precision vascular robotics, announced today that the U.S. Food and Drug Administration has cleared the CorPath®System for use in peripheral vascular interventions. This is the third clearance for...

Read more

12 Nov

Corindus Vascular Robotics Reports Third Quarter 2015 Results

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics, Inc. , a leading developer of precision vascular robotics, today reported financial results for the three and nine months ended September 30, 2015. Recent Highlights and Accomplishments Installed two new CorPath® systems increasing the total installed base to 34 CorPathSystems Revenues of...

Read more

10 Nov

Corindus Vascular Robotics to Participate in Upcoming Investor Conferences

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics, Inc. (NYSE MKT: CVRS), a leading developer of precision vascular robotics, today announced that the Company will be participating in two upcoming investor conferences. Corindus’ management is scheduled to participate in the Barclays SMID Cap Conference in New York, NY on Monday, November...

Read more

5 Nov

Corindus Vascular Robotics to Hold 2015 Third Quarter Financial Results Conference Call on November 12, 2015

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics, Inc. (NYSE MKT:CVRS), a leading developer of precision vascular robotics, today announced that the Company will release 2015 third quarter financial results after market close on Thursday, November 12, 2015. Company management will host an investment-community conference call beginning at 4:30 p.m. Eastern...

Read more

12 Oct

Corindus Vascular Robotics and Mayo Clinic Launch Vascular Robotic Program to Research Physician Safety

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE MKT: CVRS) today announced the formation of a joint robotic-assisted percutaneous coronary intervention (PCI) research and clinical program. The program utilizes the company’s CorPath® System, the first and only FDA-cleared medical device to provide robotic-assisted precision to coronary PCI procedures while protecting hospital employees...

Read more

6 Oct

FDA Clears CorPath® System for Robotic-assisted Radial Access PCI Procedures

CorPath System Provides Important Protection from Occupational Hazards in Growing Radial PCI Market WALTHAM, Mass.–(BUSINESS WIRE)–  Corindus Vascular Robotics, Inc. , a leading developer of precision vascular robotics, announced today that the U.S. Food and Drug Administration has given 510(k) clearance for its robotic-assisted CorPath System to...

Read more

Page 1 of 212

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address